Anda di halaman 1dari 3

Regional Band 6 Pharmacist Interview Feedback June 2017

Question Strong candidate answers Weaker candidate answers


You are final checking an Checked if other strengths are available in Escalated the issue to a more senior
additional stock requisition in the pharmacy which could be used to make up the colleague without first making an attempt
dispensary and notice that the dose to resolve the issue themselves
pharmacy technician has not Did not think of using other
Confirmed if patient had their own medicines
supplied the Levetiracetam formulations/strengths
that could be brought in and used
tablets requested by a ward for a Did not mention that antiepileptics are
patient taking 500mg BD. Checked if the medication could be supplied in critical medicines
They have annotated the order an alternative form e.g. liquid Did not consider education of the
with No Stock On Order. Checked the pharmacy computer system to technician to avoid recurrence
What would you do next in this see if any wards had it as stock or may have
scenario?
received it recently.
If no drug available in the hospital or
dispensary, considered checking other
hospitals for stock.
Got a supply from wholesaler if no other
options were available
Mentioned educating the pharmacy technician
on the importance of supply of essential
medicines like antiepileptics.
Shared any learning with their team
Can you name the four NOACS Were able to name the 4 NOACs Were not able to name 4 NOACs
currently licensed in the UK?
Under advantages the candidate mentioned
What are the advantages and they had similar efficacy to warfarin, had no Weaker candidates were not able to
disadvantages of the NOACs requirement to monitor anticoagulation / INR, describe in sufficient detail the clinical
compared to warfarin? had a fixed oral dose for most patients and a advantages and disadvantages of this drug
quick onset (and off set) of action. group and relate them to alternative
Under disadvantages these candidates therapies.
mentioned that there was limited reversal
options whereas reversal agents exist for
warfarin and that specific antidotes have not
yet been fully developed and evaluated for all
the NOACs. Also that NOACs Should be
avoided in severe hepatic impairment and are
contraindicated in severe renal impairment.

Under risks strong candidates mentioned the Weaker candidates were not able to
What are the potential risks of lack of awareness that NOACs are describe in sufficient detail the risks
using NOACs and how could these anticoagulants and how this can lead to them associated with this drug group or suggest
be prevented being co-prescribed with another antiplatelet suitable prevention/management
or anticoagulant agent. Also that 2 of the strategies for those risks
NOACs require a loading dose for a defined
number of days before reducing to a
maintenance dose and that there is a risk of
bleeding and greater harm if the loading dose
is not reduced to the maintenance after this
loading dose phase:
Prevention/management strategies
mentioned showed an understanding of how
to effectively manage the risks mentioned
You are clinical checking a The stronger candidates started their answer Weaker candidates did not go into sufficient
Patients prescription chart on the by saying that they would review the patients detail on the medication issues that need to
ward and you note that the medication to check if any could be stopped. be addressed when a patient is switched to a
patient has a PEG tube in situ and They then checked if the medications were PEG tube, including communication to
is on an enteral feed. available in alternative form such as liquids, community based colleagues.
The doctor has prescribed the soluble tablets, can the tablets be crushed or They also did not consider that the patient
patients medication in the form were patches available. and/or their carer need to be educated on
of tablets. Tell me how you would how to manage this themselves
go about to make sure the patient They also mentioned using the Newt Guidelines
receives their medication and/or Handbook of Drug Administration via
enteral feeding tubes
They checked for interactions between the
medication and enteral feed and the timing of the
enteral feed and the medication doses.
They also mentioned counselling the patient /
carer on the administration of the medicines prior
to discharge, for example use of oral syringes,
bungs in bottles and flushing before and after
administration of medicines, etc..

They communicated with the community


pharmacist and GP on discharge.